Literature DB >> 7887934

A truncated isoform of human CCK-B/gastrin receptor generated by alternative usage of a novel exon.

A Miyake1.   

Abstract

An isoform cDNA of CCK-B/gastrin receptor was isolated from human stomach. This cDNA differed from initially cloned cDNA only in the 5'-end region and encoded a truncated isoform (delta CCK-B) in which the putative N-terminal extracellular domain of the CCK-B/gastrin receptor was completely lost. Isolation of genomic CCK-B/gastrin receptor DNA revealed that this transcript is generated by alternative usage of a novel exon, termed exon 1b. Human stomach expressed both transcripts of delta CCK-B and entire CCK-B/gastrin receptor (CCK-BR), whereas human stomach cancer cell line AGS exclusively expressed delta CCK-B transcripts. Transfection of COS-7 with delta CCK-B cDNA led to the appearance of binding sites for 125I-CCK-8. Its ligand selectivity was different from that of CCK-BR. These results suggest the molecular diversity in CCK-B/gastrin receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7887934     DOI: 10.1006/bbrc.1995.1328

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Pharmacological comparison of the alternatively spliced short and long CCK2 receptors.

Authors:  M F Morton; E A Harper; I A Tavares; N P Shankley
Journal:  Br J Pharmacol       Date:  2003-08-04       Impact factor: 8.739

2.  Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol.

Authors:  Ross M Potter; Kaleeckal G Harikumar; S Vincent Wu; Laurence J Miller
Journal:  J Lipid Res       Date:  2011-10-21       Impact factor: 5.922

3.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

4.  Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production.

Authors:  Rocchina Colucci; Corrado Blandizzi; Marzia Tanini; Cristina Vassalle; Maria Cristina Breschi; Mario Del Tacca
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

5.  Proliferative effects of cholecystokinin in GH3 pituitary cells mediated by CCK2 receptors and potentiated by insulin.

Authors:  A J Smith; R M McKernan
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

6.  A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.

Authors:  S A Watson; T M Morris; A Varro; D Michaeli; A M Smith
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

7.  Glycine-extended gastrin exerts growth-promoting effects on human colon cancer cells.

Authors:  V M Stepan; M Sawada; A Todisco; C J Dickinson
Journal:  Mol Med       Date:  1999-03       Impact factor: 6.354

8.  Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence.

Authors:  A M Smith; S A Watson
Journal:  Gut       Date:  2000-12       Impact factor: 23.059

9.  Distinct expression and ligand-binding profiles of two constitutively active GPR17 splice variants.

Authors:  T Benned-Jensen; M M Rosenkilde
Journal:  Br J Pharmacol       Date:  2010-02-08       Impact factor: 8.739

10.  Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines.

Authors:  D F McWilliams; S A Watson; D M Crosbee; D Michaeli; R Seth
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.